glp-1 for menopause weight gain The GLP-1/GIP dual-receptor agonist tirzepatide led to at least 15% loss of total body fat in premenopausal, perimenopausal, and postmenopausal women, but postmenopausal women taking menopausal hormone therapy had the greatest A New Study Says That

Zepbound is FDA-approved for chronic weight management and may offer enhanced results for patients struggling with obesity or weight-related health concerns

It also stimulates collagen production, a protein that supports skin's firmness and elasticity

Blissenbachs direct contact information and can reach the Blissful Wellness team during business hours via phone, text, or secure messaging

Meanwhile, a study published on April 17, 2026, suggested that taking a drug like semaglutide (the main ingredient in Ozempic) may be associated with an increased risk of some patients experiencing hair loss

2) I also had an eyelid infection during this time